CLINICAL_TRIALS ClinicalTrials.gov record update

Long-acting Versus Short-acting Granulocyte Colony Stimulating Factor for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer Patients: A Multicenter Phase 3 Randomized Controlled Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04101760
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:32.979377+00:00
Published At: 2019-10-08T00:00:00+00:00
Record Updated At: 2019-10-08
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Chemotherapy-induced Neutropenia", "Febrile Neutropenia, Drug-Induced", "Epithelial Ovarian Cancer", "Colony Stimulating Factors Adverse Reaction", "Granulocyte Colony Stimulating Factor", "Cost-effectiveness Analysis", "Quality of Life", "Progression-free Survival", "Overall Survival"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-10-08"
protocolSection.identificationModule.nctId: "NCT04101760"
protocolSection.identificationModule.officialTitle: "Long-acting Versus Short-acting Granulocyte Colony Stimulating Factor for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer Patients: A Multicenter Phase 3 Randomized Controlled Study"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.